China FDA Video Showcasing ‘Hard Work’ Grips Social Media
Executive Summary
The China FDA has responded to doubts about its ability to meet a ticking deadline to eliminate its notorious drug approval lag with a video, which has gone viral and become an instant hit on China social media site Wechat.
You may also be interested in...
Sanofi, Innovent Link On China Oncology Ambitions As ADCs Surge
The antibody-drug conjugate market is emerging as the next battleground for intense competition in China, with global partnerships becoming essential to win, as evidenced by a major new alliance between Innovent and Sanofi.
China-US Tensions Rise Sharply On Pelosi Visit, Will Biotech Get Burned?
Where once there were promising prospects for cross-strait collaboration, biopharma firms in mainland China and Taiwan may now find themselves looking elsewhere for partners following a controversial visit to Taipei by US House Speaker Nancy Pelosi.
China Cool On Nasal Vaccines, Backs Antivirals In Latest COVID Guidance
China’s Center for Drug and Evaluation has issued new guidance on the development of new vaccines and drugs for COVID-19 in which it backs antivirals as a key weapon, while the Politburo has shown no signs of backing away from the country's tough "COVID Zero" policies.